On this episode of Molecular Moments, Jim McNally, Ph.D., speaks with Adam Stasio, president of SciMed, whose mission is to
A3P Biomedical AB, a Swedish company specialized in advanced prostate cancer diagnostics, and BioAgilytix, a global bioanalytical services provider, have entered a partnership with the aim of introducing Stockholm3, as...
In this news article, our CEO Jim Datin discusses with Triangle Business Journal about BioAgilytix’
HAMBURG, Germany — BioAgilytix is thrilled to announce the addition of a new diagnostics tool
Bioanalytical life science company to invest $61.5 million RALEIGH: BioAgilytix Labs, LLC, a leading life
BioAgilytix has recently been awarded the 2020 Fast 50 Award by Triangle Business Journal as
PRNewswire covers the news of welcoming Kennon Broadhurst to the BioAgilytix team, bringing with him
BioAgilytix has received its Certificate of Accreditation for high complexity testing in the diagnostic immunology specialty from the Commission on Office Laboratory Accreditation (COLA) for its U.S. facility in Durham, North Carolina.
Dr. Fjording will be based at BioAgilytix’s European laboratory in Hamburg, Germany and will provide scientific and regulatory oversight to BioAgilytix’s team in the development and implementation of strategies for bioanalytical assay development and regulated assay validation.
The new name is reflective of BioAgilytix’s plan, which was set forth following its acquisition of Boston-based Cambridge Biomedical in late 2019, to fully integrate Cambridge Biomedical’s clinical and diagnostic testing capabilities into BioAgilytix’s global service offerings.
BioAgilytix supplies its assay expertise to describe the appropriate analytical assays needed to determine and
In this role, Dr. Briscoe will provide scientific and regulatory oversight to BioAgilytix’s global teams with strategic guidance in line with emerging scientific developments.
In this role, Dr. Nicholson will oversee bioanalytical operations and scientific team development across BioAgilytix’s laboratories in both the USA and Europe, with particular focus leading the organization’s Gene and Cell Therapy bioanalytical services.
In this role, Dr. Horling will lead Operations, Finance, HR, and Facilities for BioAgilytix’s European business and its laboratory located in Hamburg, Germany.